Search results
Erasca kicks off Phase III trial for naporafenib combo therapy in melanoma
Clinical Trials Arena via Yahoo Finance· 6 hours agoThe study’s primary endpoints include objective response rate, progression free survival and plasma...
Conservationists celebrate arrival of rare wildcat kittens | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 8 hours agoConservationists are celebrating the arrival of wildcat kittens – one of Britain’s rarest mammals....
First Suffolk Punch foal born at Abbot's Hall in 100 years
BBC News· 6 days agoA museum has been celebrating the first birth of a rare horse on the site for 100 years. The Food...
Northern Arizona University researchers aim to get 100% stroke survival rate
KTVK 3TV Phoenix· 21 hours agoOrganization, stroke is the second leading cause of death worldwide and the leading cause of...
Researchers document record-breaking shark migration: 'Highlighting the need for a coordinated...
The Cool Down via Yahoo News· 5 days agoIn a recent study, the adult female silky shark — nicknamed "Genie" — was tagged with a satellite...
Video Shows Uncontacted Tribe Beg For Food From Miners Who Destroy Their Land
IFLScience· 5 days agoA shocking new video shows members of an uncontacted tribe in Indonesia approach the miners who are...
What not to eat when it's hot out
New Hampshire Union Leader· 5 hours agoIf you're trying to beat the heat this week, you might want to reconsider what you're eating and drinking. A punishing summer heat wave is baking large...
AstraZeneca Imfinzi regimen for endometrial cancer gains FDA approval
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe Lynparza and Imfinzi arm also met the trial's primary endpoint of progression-free survival...
Black Homesteaders Are Finding Freedom Through Sustainable Living—You Can, Too
Parents via Yahoo News· 1 day ago“I work in corporate America and always felt I had no real hard skills for actual living,” Butler...
Regeneron touts success with bispecific antibody in multiple myeloma trial
Clinical Trials Arena via Yahoo Finance· 1 day agoRegeneron said that the therapy is under review by the US Food and Drug Administration with a target...
